From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting
Rowe, Steven P., Luber, Brandon, Makell, Monique, Brothers, Patricia, Santmyer, JoAnn, Schollenberger, Megan D., Quinn, Hannah, Edelstein, Daniel L., Jones, Frederick S., Bleich, Karen B., Sharfman, William H., Lipson, Evan J.
Published in Molecular oncology (01.10.2018)
Published in Molecular oncology (01.10.2018)
Get full text
Journal Article
A multidisciplinary toxicity team for cancer immunotherapy-related adverse events
Naidoo, Jarushka, Cappelli, Laura, Lipson, Evan J., Forde, Patrick M., Sharfman, William Howard, Zhang, Jiajia, Mammen, Jenna, Moseley, Kendall, Suresh, Karthik, Mehta, Seema, Sander, Inbal, Probasco, John, Parian, Alyssa, Rouf, Rosanne, Berkenstock, Meghan, Brothers, Patricia, Riemer, Joanne, Emens, Leisha A., Bingham, Clifton O., Brahmer, Julie R.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
Lipson, Evan J, Lilo, Mohammed T, Ogurtsova, Aleksandra, Esandrio, Jessica, Xu, Haiying, Brothers, Patricia, Schollenberger, Megan, Sharfman, William H, Taube, Janis M
Published in Journal for immunotherapy of cancer (21.03.2017)
Published in Journal for immunotherapy of cancer (21.03.2017)
Get full text
Journal Article
A phase 2 study of nivolumab (NIVO) alone or plus ipilimumab (IPI) for patients with locally advanced unresectable (laBCC) or metastatic basal cell carcinoma (mBCC)
Stein, Julie E., Brothers, Patricia, Applebaum, Katie, Gaskin, Angela, Wang, Hao, Taube, Janis M., Lipson, Evan J.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article